Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice.
about
Dynamic visualization of RANKL and Th17-mediated osteoclast function.Bisphosphonates and bone quality.Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in miceDistinctive tooth-extraction socket healing: bisphosphonate versus parathyroid hormone therapy.Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ)Mouse anti-RANKL antibody delays oral wound healing and increases TRAP-positive mononuclear cells in bone marrow.Intra-oral PTH administration promotes tooth extraction socket healing.Effect of zoledronate on the responses of osteocytes to acute parathyroid hormone.Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing.Osteonecrosis of the Jaw-a Bone Site-Specific Effect of Bisphosphonates.Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.Basic fibroblast growth factor attenuates bisphosphonate-induced oxidative injury but decreases zinc and copper levels in oral epithelium of rat.Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease.Local vs. systemic administration of bisphosphonates in rat cleft bone graft: A comparative study.Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice.Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice.
P2860
Q30533914-CAE4D607-EC4C-447D-8093-DA32C08A4796Q33683219-7F84A781-F1EA-4DD2-878B-0781B6C1B6AFQ34429959-86DB6F83-6237-4296-8931-D87FE24DC9CFQ34575759-A9503F92-6473-4924-86A8-CFBE1F7E4A62Q35884204-9FA8C0F9-6314-4F95-9A49-0BA76ABA5B9EQ36823728-D8B7FF1E-DF27-48F5-8D3E-1691113BAB61Q36846307-38DC9F09-9E25-4D3B-88AB-60805123D164Q36849984-683C44F9-7D34-428E-B724-FCD73FF25A3DQ37460461-62DBB855-3DD9-446A-861D-D3CA42CC28BCQ37581504-B6E68BB8-A366-4E80-944F-571BC44643EBQ38913031-B8154A52-76F0-4B68-A7C1-CAB8E30EB671Q40509688-263D82B7-ACFC-4F8D-A40A-BA6C64873F79Q44223333-D06D622E-5D65-432E-8E33-75721DB226B0Q47099897-65E75233-3EA4-4591-A341-35803202F207Q47557494-07195789-F497-425A-94F1-92083151F3BEQ48172033-95F8E602-E775-4B97-B5DB-E37BDC2D1F89Q55413820-472C2ACD-7B84-4C88-9121-46ECEFDB6A5D
P2860
Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Increased numbers of nonattach ...... ledronic acid therapy in mice.
@ast
Increased numbers of nonattach ...... ledronic acid therapy in mice.
@en
type
label
Increased numbers of nonattach ...... ledronic acid therapy in mice.
@ast
Increased numbers of nonattach ...... ledronic acid therapy in mice.
@en
prefLabel
Increased numbers of nonattach ...... ledronic acid therapy in mice.
@ast
Increased numbers of nonattach ...... ledronic acid therapy in mice.
@en
P2860
P356
P1433
P1476
Increased numbers of nonattach ...... oledronic acid therapy in mice
@en
P2093
Virginia-Arlene A Go
P2860
P356
10.1210/EN.2011-1439
P407
P577
2011-11-22T00:00:00Z